Krystal Biotech, Inc. (KRYS) is listed on NASDAQ in Biotech Stocks. It is $351.70, -1.61%, with a $10.4B market cap. RSI is 55.2, neutral. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 55.2 Neutral
Market Cap $10.4B
Volume 89.5K
Fundamentals — 10-Q Q2 2026
Revenue $235.6M
Net Income $110.7M
EPS $3.62
Operating Margin 47.6%
Net Margin 47.0%
P/E Ratio 97.2x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Rossi Dino A | Director | Sell | 25,000 | $329.12 | $8.2M | 2026 Aug 14 |
| Thomas John Charles | EVP, General Counsel | Sell | 1,000 | $347.27 | $347,270 | 2026 Jun 25 |
| Krishnan Suma | President, R&D | Sell | 25,000 | $308.11 | $7.7M | 2026 Jun 4 |
| Krishnan Krish S | President and CEO | Sell | 25,000 | $308.12 | $7.7M | 2026 Jun 4 |
| Thomas John Charles | EVP, General Counsel | Sell | 642 | $302.03 | $193,903 | 2026 May 26 |
| Krishnan Suma | President, R&D | Sell | 25,000 | $263.21 | $6.6M | 2026 Mar 4 |
| Krishnan Krish S | President and CEO | Sell | 25,000 | $263.17 | $6.6M | 2026 Mar 4 |
| Romano Kathryn | Chief Accounting Officer | Sell | 750 | $267.60 | $200,700 | 2026 Mar 2 |
| Janney Daniel | Director | Sell | 11,803 | $275.59 | $3.3M | 2026 Feb 27 |
| Janney Daniel | Director | Sell | 60,161 | $268.44 | $16.1M | 2026 Feb 26 |
| Rossi Dino A | Director | Sell | 18,950 | $261.41 | $5.0M | 2026 Feb 19 |
| Krishnan Suma | President, R&D | Sell | 50,000 | $220.15 | $11.0M | 2025 Dec 4 |
| Krishnan Krish S | President and CEO | Sell | 50,000 | $220.15 | $11.0M | 2025 Dec 4 |
| Krishnan Krish S | President and CEO | Sell | 35,873 | $150.39 | $5.4M | 2025 Jul 16 |
| Krishnan Suma | President, R&D | Sell | 35,873 | $150.39 | $5.4M | 2025 Jul 16 |
| Krishnan Suma | President, R&D | Sell | 14,127 | $150.27 | $2.1M | 2025 Jul 10 |
| Krishnan Krish S | President and CEO | Sell | 14,127 | $150.27 | $2.1M | 2025 Jul 10 |
| Krishnan Suma | President, R&D | Sell | 50,000 | $177.79 | $8.9M | 2025 Mar 13 |
| Krishnan Krish S | President and CEO | Sell | 50,000 | $177.79 | $8.9M | 2025 Mar 13 |
| Romano Kathryn | Chief Accounting Officer | Sell | 750 | $175.22 | $131,415 | 2025 Feb 27 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $432.33 | 66.2 | $233.7B |
| | $145.64 | 60.3 | $180.6B |
| | $43.12 | 53.6 | -- |
| | $8.02 | 62.4 | $3.6B |
| | $25.20 | 55.8 | $4.0B |
Take KRYS further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put KRYS in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Krystal Biotech, Inc. next reports.
Set alerts on KRYS
Get notified when Krystal Biotech, Inc. hits your price targets or technical conditions are met.
Get Started Free